Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. S.P.C. Lam

Publicaties

A Bayesian analysis of finerenone in heart failure with mildly reduced and preserved ejection fraction: a pre-specified analysis of FINEARTS-HF

AI task-shifting for echocardiographic LVEF assessment in Singapore: an economic evaluation

Effects of Finerenone on Readmissions for Heart Failure: Insights From the FINEARTS-HF Trial

Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)

Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial

Finerenone and eGFR slope across Different Levels of Baseline Albuminuria and Estimated Glomerular Filtration Rate: Insights from FINEARTS-HF

Finerenone and New York Heart Association Functional Class in Heart Failure: The FINEARTS-HF Trial

Finerenone and Quality of Life Assessed Using the EuroQol 5-Dimension Questionnaire Level Sum Score in Patients With HFmrEF or HFpEF

Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial

Finerenone in Persons with Chronic Kidney Disease without Diabetes

Pers/media

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse

Wat is nieuw in de 2021 ESC HF richtlijn wat betreft patiënten met EF>40%?

Sustainable Development Goals

SDG 1 – Geen armoedeSDG 2 – Geen hongerSDG 3 – Goede gezondheid en welzijnSDG 8 – Fatsoenlijk werk en economische groeiSDG 10 – Minder ongelijkheid

Meer informatie over de Sustainable Development Goals.